Desire A. Nshimirimana

Desire A. Nshimirimana

Auto-generated profile, based on publicly available information

Desire A. Nshimirimana


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
RZRuvimbo Zimunya
Ruvimbo Zimunya
ASAndrina Simengwa
Andrina Simengwa
COChrisphine Onyango
Chrisphine Onyango
KOKelly Oluoch
Kelly Oluoch
DNDesire A. Nshimirimana
Desire A. Nshimirimana
This systematic review and meta-analysis aimed to estimate the overall effectiveness of ASD interventions and identify sources of heterogeneity using frequentist and Bayesian approaches. A systematic search of PubMed/MEDLINE, Embase, Web of Science, and Scopus was conducted for studies published between January 1, 2004, and April 30, 2025. Mainly, randomized controlled trial studies with extractable intervention outcomes were included. A total of 41 studies (n=3,008) were synthesized using random-effects models (REML), Bayesian hierarchical modeling, meta-regression, and sensitivity analyses following PRISMA guidelines. The pooled random-effects estimate showed a significant positive effect of ASD interventions (effect size = 0.506, 95% CI: 0.392–0.619; z = 8.72, p < .001), corresponding to an estimated success proportion of 62% (95% CI: 59%–65%). Heterogeneity was substantial (Q□(40) = 238.78, p < .001; I² = 82.45%; τ² = 0.069, 95% CI: 0.028–0.137; τ = 0.262), with H² = 5.70 and a wide prediction interval (−0.020 to 1.031), indicating strong between-study variability. Bayesian meta-analysis confirmed a comparable effect (posterior mean = 0.619, 95% CrI: 0.592–0.646), with τ = 0.273 and I² ≈ 82.5%, and MCMC diagnostics showed stable convergence (R-hat ≈ 1.00). Publication bias analyses indicated significant funnel plot asymmetry (Egger-type regression: z = 3.429, p < .001; weighted regression: t = 9.573, p < .001), while rank correlation was non-significant (τ = −0.178, p = .103). Trim-and-fill analysis imputed 10 studies, reducing the pooled effect to 0.374 (95% CI: 0.258–0.491; τ = 0.338), though the effect remained significant (p < .001). Sensitivity analyses excluding influential studies yielded a stable effect (0.505, 95% CI: 0.401–0.609), with persistent heterogeneity (I² = 75.49%; Q□(38) = 190.21, p < .001; τ² = 0.043). Subgroup analyses showed highest effects for digital/technology-based interventions (0.672; 67%; I² = 0%), followed by nutritional (0.635; 64%; I² = 73.81%), behavioral (0.630; 63%; I² = 74.78%), and pharmacological (0.627; 63%; I² = 0%) interventions, while physical/occupational therapies showed lower effects (0.523; 52%; I² = 63.35%) and combined interventions showed borderline effects (0.593; 59%; I² = 19.96%); subgroup differences were significant (Q□5) = 22.63, p < .001). Regional effects were similar and non-significant (Q□(2) = 0.73, p = .694): North America (0.619; I² = 84.21%), Europe (0.626; I² = 62.34%), and Asia (0.659; I² = 0%). Age at intervention onset did not significantly moderate effects (Q□(5) = 0.98, p = .964), although variability was observed across children, adolescents, adults, and toddlers. Meta-regression identified significant moderators including intervention context (Q□= 18.159, p = .020), outcome domain (Q□= 19.588, p = .003), age at start (Q□= 17.795, p = .003), and intervention category (Q□= 31.714, p < .001), while follow-up duration and intervention duration were not significant. Bayesian subgroup analyses confirmed robustness, with strongest evidence for pharmacological (BF → ∞), behavioral (BF ≈ 832.50), and digital interventions (BF ≈ 30.92). In conclusion, ASD interventions demonstrate a moderate and statistically significant overall effect (∼0.50–0.62), with substantial heterogeneity driven primarily by intervention type, context, and participant characteristics, and findings were consistent across frequentist, Bayesian, and sensitivity analyses, supporting robust but context-dependent effectiveness.